Pediatrix Medical Group, Inc.
corporate_fare Company Profile
Pediatrix Medical Group, Inc. (NYSE:MD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for MD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for MD spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Pediatrix 10-Q Details Q3: $501.4M Revenue, $147.2M Buybacks, Term Loan Due Feb 2027
- Pediatrix Q3 Adjusted EPS $0.72; Full-Year EBITDA Guidance Raised to $290M-$300M
- Pediatrix Posts Q3 EPS of 59 Cents
- Pediatrix Q2 2026: Adjusted EPS $0.63 Beats Estimates, Full-Year EBITDA Guidance Reaffirmed
- Pediatrix Q2 Earnings Beat with $0.63 Adjusted EPS; Reaffirms 2026 EBITDA Guidance
Financial Snapshot
Short Interest & Short Volume
5.03 days to coverFINRA reported short interest of 3,546,600 shares in MD as of the October 30, 2026 settlement, a 18.9% decrease from the prior period — about 5.0 days to cover at its recent average daily volume. On November 20, 2026, 36.6% of MD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.